Additional file 1: Figure S1. of Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes

Plasma levels of fractalkine and selective inflammatory cytokines were measured in 23 type-2 diabetic (T2D) and 24 non-diabetic individuals using magnetic bead premixed 41-plex immune assays as described in Methods. The data show that in non-diabetic individuals, systemic fractalkine levels did not associate with (A) G-CSF (r = 0.31 P = 0.14); (B) IFN-α2 (r = 0.23 P = 0.28); (C) IL-17A (r = 0.10 P = 0.78); and (D) IL-6 (r = 0.18 P = 0.45). (TIF 716 kb)